SEC Form D private-offering filing

Dash Bio, Inc.

Name: Dash Bio, Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2026-07-14

A new SEC Form D private-offering notice from Boston, MA, a $30,000,022 filer-stated offering target in Biotech. The source filing is one click away.

Dash Bio, Inc. site↗ Verified via SEC Form D

Automated bioanalysis company using robotics and AI to accelerate clinical and preclinical sample testing for drug developers.

Filed 2026-07-14Filed to raise $30,000,022First money in 2026-06-15Raised so far $30,000,022HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) GrowthCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified dash.bio↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.